翻訳と辞書 |
Australian Institute for Bioengineering and Nanotechnology : ウィキペディア英語版 | Australian Institute for Bioengineering and Nanotechnology
The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) was established in 2003. It is one of four stand-alone research institutions at the university with more than 500 researchers, students and support staff. The inaugural Director is Professor Peter Gray (2003–Present). The institute's second director, Professor Alan Rowan, will commence in 2016. The AIBN is an integrated multi-disciplinary research institute bringing together researchers in the areas of bioengineering and nanotechnology. It is home to research groups working at the interface of the biological, chemical and physical sciences, and its applications in human health and environmental issues. Notable work performed by the institute includes the needleless Nanopatch vaccine delivery device that is ready to begin human trials; local production of an experimental antibody for the treatment of the Hendra virus; and biofuel research. ==Research== AIBN's research efforts are focused in the areas of: * Nanotechnology-based imaging and drug delivery for therapeutic products; * Regenerative medicine: biology, stem cells and novel scaffolds; * Novel protein expression utilising metabolomics and systems biotechnology; * Nanotechnology for energy and environmental applications.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Australian Institute for Bioengineering and Nanotechnology」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|